I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 11 studies | 21% ± 4% | |
| epithelial cell | 6 studies | 36% ± 19% | |
| basal cell | 6 studies | 26% ± 7% | |
| CD4-positive, alpha-beta T cell | 5 studies | 23% ± 10% | |
| naive B cell | 4 studies | 17% ± 2% | |
| B cell | 4 studies | 20% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 18% ± 1% | |
| fibroblast | 4 studies | 22% ± 3% | |
| pericyte | 4 studies | 17% ± 2% | |
| natural killer cell | 4 studies | 22% ± 5% | |
| pancreatic A cell | 3 studies | 24% ± 3% | |
| hematopoietic precursor cell | 3 studies | 25% ± 10% | |
| ciliated cell | 3 studies | 32% ± 7% | |
| GABAergic neuron | 3 studies | 23% ± 7% | |
| glutamatergic neuron | 3 studies | 30% ± 8% | |
| CD8-positive, alpha-beta T cell | 3 studies | 24% ± 8% | |
| dendritic cell | 3 studies | 35% ± 14% | |
| transit amplifying cell | 3 studies | 23% ± 7% | |
| erythroblast | 3 studies | 30% ± 7% |
